This invited commentary offers insights into a manuscript that provides a deeper understanding of the perioperative outcomes of patients with stage II/IV non-small-cell lung cancer (NSCLC) with tumour resection after neoadjuvant immunotherapy, alone or as part of multimodal treatment.
Re: Two Centres’ Experience With Lung Cancer Resection in Patients With Advanced Non-Small-Cell Lung Cancer Following Treatment With Immune Checkpoint Inhibitors: Safety and Clinical outcomes
Source: European Journal of Cardio-Thoracic Surgery
Source URL: https://doi.org/10.1093/ejcts/ezab399
Keywords:
Author(s): Bertrand Mennecier, Anne Olland, Céline Mascaux, Pierre-Emmanuel Falcoz